1. Cost‐effectiveness analysis of trastuzumab emtansine (T‐DM1) in treating HER‐2 positive advanced breast cancer in Taiwan. Issue 10 (17th September 2020) Authors: Wang, Lin‐Chien; Kuo, Chun‐Nan; Ko, Yu Journal: Breast journal Issue: Volume 26:Issue 10(2020) Page Start: 2099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗